- Home
- WSBC vs VKTX Comparison
WSBC vs VKTX Comparison
Compare WSBC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSBC
- VKTX
- Stock Information
- Founded
- WSBC 1870
- VKTX 2012
- Country
- WSBC United States
- VKTX United States
- Employees
- WSBC N/A
- VKTX N/A
- Industry
- WSBC Major Banks
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- WSBC Finance
- VKTX Health Care
- Exchange
- WSBC Nasdaq
- VKTX Nasdaq
- Market Cap
- WSBC 2.6B
- VKTX 2.8B
- IPO Year
- WSBC N/A
- VKTX 2015
- Fundamental
- Price
- WSBC $30.35
- VKTX $26.45
- Analyst Decision
- WSBC Buy
- VKTX Buy
- Analyst Count
- WSBC 6
- VKTX 12
- Target Price
- WSBC $38.50
- VKTX $84.00
- AVG Volume (30 Days)
- WSBC 443.2K
- VKTX 2.9M
- Earning Date
- WSBC 07-24-2025
- VKTX 07-23-2025
- Dividend Yield
- WSBC 4.81%
- VKTX N/A
- EPS Growth
- WSBC N/A
- VKTX N/A
- EPS
- WSBC 1.44
- VKTX N/A
- Revenue
- WSBC $569,805,000.00
- VKTX N/A
- Revenue This Year
- WSBC $42.42
- VKTX N/A
- Revenue Next Year
- WSBC $12.79
- VKTX N/A
- P/E Ratio
- WSBC $21.33
- VKTX N/A
- Revenue Growth
- WSBC N/A
- VKTX N/A
- 52 Week Low
- WSBC $25.56
- VKTX $18.92
- 52 Week High
- WSBC $37.36
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- WSBC 49.25
- VKTX 46.23
- Support Level
- WSBC $29.59
- VKTX $26.66
- Resistance Level
- WSBC $31.59
- VKTX $28.33
- Average True Range (ATR)
- WSBC 0.58
- VKTX 1.34
- MACD
- WSBC -0.13
- VKTX -0.19
- Stochastic Oscillator
- WSBC 41.90
- VKTX 13.86
About WSBC WesBanco Inc.
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.